| 产品编号 | CFN70256 | |
| CAS编号 | 1055329-49-1 | |
| 分子式 = 分子量 | C36H58O9 = 634.9 | |
| 产品纯度 | >=98% | |
| 物理属性 | Powder | |
| 化合物类型 | Triterpenoids | |
| 植物来源 | The herbs of Sutherlandia frutescens | |
| ChemFaces的产品在影响因子大于5的优秀和顶级科学期刊中被引用 | ||
| 产品名称 | 产品编号 | CAS编号 | 包装 | QQ客服 |
| Sutherlandioside D | CFN70256 | 1055329-49-1 | 1mg | QQ客服:3004468520 |
| Sutherlandioside D | CFN70256 | 1055329-49-1 | 5mg | QQ客服:3004468520 |
| Sutherlandioside D | CFN70256 | 1055329-49-1 | 10mg | QQ客服:3004468520 |
| Sutherlandioside D | CFN70256 | 1055329-49-1 | 20mg | QQ客服:3004468520 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)| Description: | Sutherlandioside D may exert anti-cancer effect by targeting Gli/Hh signaling. |
| Targets: | Gli/Hh |
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 1.5751 mL | 7.8753 mL | 15.7505 mL | 31.501 mL | 39.3763 mL |
| 5 mM | 0.315 mL | 1.5751 mL | 3.1501 mL | 6.3002 mL | 7.8753 mL |
| 10 mM | 0.1575 mL | 0.7875 mL | 1.5751 mL | 3.1501 mL | 3.9376 mL |
| 50 mM | 0.0315 mL | 0.1575 mL | 0.315 mL | 0.63 mL | 0.7875 mL |
| 100 mM | 0.0158 mL | 0.0788 mL | 0.1575 mL | 0.315 mL | 0.3938 mL |
| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 6,9,10-三羟基-7-巨豆烯-3-酮; 6,9,10-Trihydroxy-7-megastigmen-3-one | CFN98717 | 476682-97-0 | C13H22O4 = 242.3 | 5mg | QQ客服:3004468091 |
| 1-chloro-6-(5-(prop-1-ynyl)thiophen-2-yl)hexa-3,5-diyn-2-ol; 1-chloro-6-(5-(prop-1-ynyl)thiophen-2-yl)hexa-3,5-diyn-2-ol | CFN97270 | 78876-52-5 | C13H9ClOS = 248.7 | 5mg | QQ客服:3004468091 |
| 2-二甲氨基乙基磷酸; 2-Dimethylaminoethylphosphonic acid | CFN00034 | 14596-56-6 | C4H12NO3P = 153.12 | 5mg | QQ客服:3004468087 |
| 乙酸苄酯; Benzyl acetate | CFN70064 | 140-11-4 | C9H10O2 = 150.1 | 20mg | QQ客服:3004468088 |